Shigeo Tamiya

Ohio State University

$2,028,534

Attributed

$2,251,165

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $794.2K · FY2020–24

$1M$750K$500K$250K$0

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$2,251,165 · 2

By mechanism

R01$1,805,903 · 1

R21$445,262 · 1

Top collaborators

Zhao-Hui Song1 shared

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Prevention”

Bambra Strokes · Ppd Development Lp$526,656,217
Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
Kimberly Smith · Ppd Development Lp$115,671,664
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673

Research focus

PreventionSmall Hairpin RnaMolecularPreventReceptorS CellIn VivoLiteratureMuller&AposOperative Surgical ProceduresExtracellular MatrixProliferative VitreoretinopathyRetinaRetinal DetachmentFibrosisCellsCell TypeKnock-DownCicatrixBlindnessMyofibroblastNuclearComplicationStructure Of Retinal Pigment Epithelium

Grant awards (7)

Role of MRTF signaling in proliferative vitreoretinopathy$347,806

R01 · FY2024 · EY · contact PI

Endocannabinoid system as a therapeutic target for PVR$445,262

R21 · FY2023 · EY

Role of MRTF signaling in proliferative vitreoretinopathy$348,961

R01 · FY2023 · EY · contact PI

Role of MRTF signaling in proliferative vitreoretinopathy$340,836

R01 · FY2022 · EY · contact PI

Role of MRTF signaling in proliferative vitreoretinopathy$256,793

R01 · FY2021 · EY · contact PI

Role of MRTF signaling in proliferative vitreoretinopathy$121,507

R01 · FY2021 · EY · contact PI

Role of MRTF signaling in proliferative vitreoretinopathy$390,000

R01 · FY2020 · EY · contact PI